Advocos and MD Scientific Sign Multi-Year Promotional Agreement; Advocos LLC Sales Teams to Represent MD Scientific's EndoTool(TM).

KENNESAW, Ga. -- Advocos LLC, a contract sales organization which provides sales and marketing services to the pharmaceutical, bio-tech and medical device industries, today announced that it has entered into a multi-year agreement with Charlotte, North Carolina-based MD Scientific, LLC to promote EndoTool(TM) Glucose Management System to hospitals.

EndoTool(TM) Glucose Management System received FDA clearance on June 20 2006. Under this promotional agreement, Advocos LLC will provide multiple sales teams to be launched in August and October 2006, with the potential to expand the sales teams over time.

Robert Godfrey, President of Advocos LLC, said, "Our experience within the hospital sector provides Advocos with the background to quickly launch and impact this market. We are excited about the opportunity to work with MD Scientific in an effort to increase awareness while also expanding the use of EndoTool(TM) within hospitals throughout the United States."

Shade Mecum, CEO of MD Scientific stated, "As we grow EndoTool(TM), we sought a strategic partner which could assist us with our evolution and expansion. Advocos and its team fit the bill." Mecum continues, "As our reach expands nationally, we continue to build out the team that can help ensure the impact of EndoTool(TM) and safe glucose control in critical care settings."

Susan Derence, Advocos' Vice President of Business Development added, "Several studies have revealed clinical and economic benefits of a Tight Glycemic Control program. We look forward to the opportunity to promote a product that provides hospital intensive care units the opportunity to reduce their infection rates, while also reducing the overall cost of patient care."